Fertility drugs and cancer: a guideline
- PMID: 27573989
- DOI: 10.1016/j.fertnstert.2016.08.035
Fertility drugs and cancer: a guideline
Abstract
Methodological limitations in studying the association between the use of fertility drugs and cancer include the inherent increased risk of cancer in women who never conceive, the low incidence of most of these cancers, and that the age of diagnosis of cancer typically is many years after fertility drug use. Based on available data, there does not appear to be a meaningful increased risk of invasive ovarian cancer, breast cancer, or endometrial cancer following the use of fertility drugs. Several studies have shown a small increased risk of borderline ovarian tumors; however, there is insufficient consistent evidence that a particular fertility drug increases the risk of borderline ovarian tumors, and any absolute risk is small. Given the available literature, patients should be counseled that infertile women may be at an increased risk of invasive ovarian, endometrial, and breast cancer; however, use of fertility drugs does not appear to increase this risk.
Copyright © 2016. Published by Elsevier Inc.
Similar articles
-
Fertility drug use and the risk of ovarian tumors in infertile women: a case-control study.Fertil Steril. 2013 Jun;99(7):2031-6. doi: 10.1016/j.fertnstert.2013.02.010. Epub 2013 Apr 1. Fertil Steril. 2013. PMID: 23552324 Free PMC article.
-
Are infertility treatments a potential risk factor for cancer development? Perspective of 30 years of follow-up.Gynecol Endocrinol. 2012 Oct;28(10):809-14. doi: 10.3109/09513590.2012.671391. Epub 2012 Apr 5. Gynecol Endocrinol. 2012. PMID: 22475084
-
Too early to determine cancer risk from infertility treatments.J Natl Cancer Inst. 2012 Apr 4;104(7):501-2. doi: 10.1093/jnci/djs197. Epub 2012 Mar 22. J Natl Cancer Inst. 2012. PMID: 22440681 No abstract available.
-
Association between fertility drugs and gynecologic cancers, breast cancer, and childhood cancers.Acta Obstet Gynecol Scand. 2004 Dec;83(12):1104-11. doi: 10.1111/j.0001-6349.2004.00669.x. Acta Obstet Gynecol Scand. 2004. PMID: 15548140 Review.
-
Use of HRT and the subsequent risk of cancer.J Epidemiol Biostat. 1999;4(3):191-210; discussion 210-5. J Epidemiol Biostat. 1999. PMID: 10695959 Review.
Cited by
-
BRCA, infertility, and fertility preservation: a review for counseling.J Assist Reprod Genet. 2023 Mar;40(3):465-472. doi: 10.1007/s10815-023-02725-y. Epub 2023 Jan 25. J Assist Reprod Genet. 2023. PMID: 36695945 Free PMC article. Review.
-
Women With a History of Primary Infertility and Increased Rates of Bilateral Oophorectomy.Obstet Gynecol. 2022 Oct 1;140(4):643-653. doi: 10.1097/AOG.0000000000004916. Epub 2022 Sep 7. Obstet Gynecol. 2022. PMID: 36075082 Free PMC article.
-
Effect of Neuroendocrine Neoplasm Treatment on Human Reproductive Health and Sexual Function.J Clin Med. 2022 Jul 8;11(14):3983. doi: 10.3390/jcm11143983. J Clin Med. 2022. PMID: 35887747 Free PMC article. Review.
-
Diagnosis and Management of Infertility: A Review.JAMA. 2021 Jul 6;326(1):65-76. doi: 10.1001/jama.2021.4788. JAMA. 2021. PMID: 34228062 Free PMC article. Review.
-
A Potential Pathogenic Link Between Cancer of Female Reproductive System and Infertile Women Treated With Assisted Reproduction Techniques.In Vivo. 2021 May-Jun;35(3):1393-1399. doi: 10.21873/invivo.12391. Epub 2021 Apr 28. In Vivo. 2021. PMID: 33910816 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical